Where Are We Now and Where Might We Be Headed in Understanding and Managing Brain Metastases in Colorectal Cancer Patients?

Compared to liver and lung metastases, brain metastases (BMs) from colorectal cancer (CRC) are rare and remain poorly investigated despite the anticipated rise in their incidence. CRC patients bearing BM have a dismal prognosis with a median survival of 3–6 months, significantly lower than that of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mjahed, Ribal Bou, Astaras, Christoforos, Roth, Arnaud, Koessler, Thibaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Lower Gastrointestinal Cancers (AB Benson, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174111/
https://www.ncbi.nlm.nih.gov/pubmed/35482170
http://dx.doi.org/10.1007/s11864-022-00982-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174111/
https://www.ncbi.nlm.nih.gov/pubmed/35482170
http://dx.doi.org/10.1007/s11864-022-00982-0

Ejemplares similares